| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.34 | 0.2 |